Cargando…

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil

INTRODUCTION: Chronic hepatitis C virus infection is one of the major causes of cirrhosis, hepatocellular carcinoma and liver transplantation. Treatment using direct-acting antivirals has revolutionized the treatment of hepatitis C virus, increasing long-term prognosis after cure. The goal of the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holzmann, Iandra, Tovo, Cristiane V., Minmé, Roseline, Leal, Mônica P., Kliemann, Michele P., Ubirajara, Camila, Aquino, Amanda A., Araujo, Bruna, Almeida, Paulo R.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427950/ https://www.ncbi.nlm.nih.gov/pubmed/30036490 http://dx.doi.org/10.1016/j.bjid.2018.06.004

Ejemplares similares

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil
por: Pereira, Camila V, et al.
Publicado: (2016)

Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil
por: Vaucher, Manoela Badinelli, et al.
Publicado: (2023)

Identification of hepatitis B virus A1762T/G1764A double mutant strain in patients in Southern Brazil
por: Silva Souza, Adaliany Cecília da, et al.
Publicado: (2017)

Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study
por: Marcon, Patrícia dos Santos, et al.
Publicado: (2018)

Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
por: Antonello, Vicente Sperb, et al.
Publicado: (2013)

Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes
por: Rossato, Giovana, et al.
Publicado: (2019)

Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
por: Lourenço, Mariana Sandoval, et al.
Publicado: (2022)

The bottleneck in ENT graduate programs in Brazil
por: Martins, Regina, et al.
Publicado: (2015)

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study
por: Pereira, Gustavo H., et al.
Publicado: (2022)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil
por: Ferreira, Vinicius Lins, et al.
Publicado: (2018)

Parasites and diet of Serrasalmus maculatus in a hydroelectric reservoir in Brazil
por: Miguel, Bianca da Silva, et al.
Publicado: (2022)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
por: Leal, Cassia, et al.
Publicado: (2023)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015)

Influenza Antiviral Subversion: Now the Host Is in on the Act
por: Yepsen, Erin N., et al.
Publicado: (2021)

Evaluation of Behavioral and Pharmacological Effects of Hydroalcoholic Extract of Valeriana prionophylla Standl. from Guatemala
por: Holzmann, Iandra, et al.
Publicado: (2011)

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
por: Appel-da-Silva, Marcelo Campos, et al.
Publicado: (2016)

An expert review on breaking barriers in severe asthma in Brazil: Time to act
por: Pitrez, Paulo Márcio, et al.
Publicado: (2021)

New species and new records in Cerambycidae (Coleoptera) of the state of Bahia, Brazil
por: Galileo, Maria Helena M., et al.
Publicado: (2015)

Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
por: Rodrigues, João Paulo Vilela, et al.
Publicado: (2022)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
por: Karayiannis, Peter
Publicado: (2012)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

Socioeconomic Determinants of Antibiotic Consumption in the State of São Paulo, Brazil: The Effect of Restricting Over-The-Counter Sales
por: Kliemann, Breno S., et al.
Publicado: (2016)

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
por: Smolders, E. J., et al.
Publicado: (2016)

Calcium-sensing receptor acts as an antiviral factor for rotavirus infections and participates in cellular antiviral response
por: Huang, Haohai, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil
por: Titton, Carolina Moro, et al.
Publicado: (2023)

A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
por: Balk, Ethan M., et al.
Publicado: (2022)

High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil
por: Buonafine, Carolina Palamin, et al.
Publicado: (2020)

Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study
por: Volpato, Sofia, et al.
Publicado: (2017)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Natural killer cells act as rheostats modulating antiviral T cells
por: Waggoner, Stephen N., et al.
Publicado: (2011)

Psychiatric treatment considerations with direct acting antivirals in hepatitis C
por: Sockalingam, Sanjeev, et al.
Publicado: (2013)

The great balancing act: regulation and fate of antiviral T‐cell interactions
por: Moseman, E. Ashley, et al.
Publicado: (2013)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)

Spindle-E Acts Antivirally Against Alphaviruses in Mosquito Cells
por: Varjak, Margus, et al.
Publicado: (2018)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
por: Dias Junior, Antonio Gregorio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rrfvkvijufhrd2ufvpmursudk1